Sveriges Riksbank
RESULT OF RIKSBANK REVERSED AUCTIONS SEK COVERED BONDS
| Auction date | 2021-02-11 |
| Loan | 192 |
| Coupon | 1.00 % |
| ISIN-code | SE0010133207 |
| Maturity | 2023-03-15 |
| Tendered volume, SEK mln | 900 +/- 450 |
| Volume offered, SEK mln | 4,300 |
| Volume bought, SEK mln | 900 |
| Number of bids | 9 |
| Number of accepted bids | 3 |
| Average yield | -0.060 % |
| Lowest accepted yield | -0.060 % |
| Highest yield | -0.058 % |
| % accepted at lowest yield | 87.50 |
| Auction date | 2021-02-11 |
| Loan | 1586 |
| Coupon | 4.50 % |
| ISIN-code | SE0003174838 |
| Maturity | 2022-09-21 |
| Tendered volume, SEK mln | 1,700 +/- 1,000 |
| Volume offered, SEK mln | 8,900 |
| Volume bought, SEK mln | 1,700 |
| Number of bids | 15 |
| Number of accepted bids | 4 |
| Average yield | -0.074 % |
| Lowest accepted yield | -0.075 % |
| Highest yield | -0.069 % |
| % accepted at lowest yield | 45.00 |
| Auction date | 2021-02-11 |
| Loan | 143 |
| Coupon | 1.25 % |
| ISIN-code | SE0008586655 |
| Maturity | 2022-06-15 |
| Tendered volume, SEK mln | 800 +/- 400 |
| Volume offered, SEK mln | 2,740 |
| Volume bought, SEK mln | 800 |
| Number of bids | 7 |
| Number of accepted bids | 3 |
| Average yield | -0.087 % |
| Lowest accepted yield | -0.093 % |
| Highest yield | -0.083 % |
| % accepted at lowest yield | 83.33 |
| Auction date | 2021-02-11 |
| Loan | 575 |
| Coupon | 1.50 % |
| ISIN-code | SE0010546572 |
| Maturity | 2022-12-21 |
| Tendered volume, SEK mln | 800 +/- 400 |
| Volume offered, SEK mln | 2,450 |
| Volume bought, SEK mln | 800 |
| Number of bids | 5 |
| Number of accepted bids | 3 |
| Average yield | -0.070 % |
| Lowest accepted yield | -0.075 % |
| Highest yield | -0.063 % |
| % accepted at lowest yield | 90.00 |
| Auction date | 2021-02-11 |
| Loan | 515 |
| Coupon | 2.25 % |
| ISIN-code | SE0007278429 |
| Maturity | 2022-09-21 |
| Tendered volume, SEK mln | 700 +/- 350 |
| Volume offered, SEK mln | 2,300 |
| Volume bought, SEK mln | 700 |
| Number of bids | 6 |
| Number of accepted bids | 1 |
| Average yield | -0.075 % |
| Lowest accepted yield | -0.075 % |
| Highest yield | -0.075 % |
| % accepted at lowest yield | 100.00 |
| Auction date | 2021-02-11 |
| Loan | 2212 |
| Coupon | 1.00 % |
| ISIN-code | SE0010297085 |
| Maturity | 2022-12-21 |
| Tendered volume, SEK mln | 300 +/- 150 |
| Volume offered, SEK mln | 1,550 |
| Volume bought, SEK mln | 300 |
| Number of bids | 6 |
| Number of accepted bids | 1 |
| Average yield | -0.055 % |
| Lowest accepted yield | -0.055 % |
| Highest yield | -0.055 % |
| % accepted at lowest yield | 100.00 |
| Auction date | 2021-02-11 |
| Loan | 5531 |
| Coupon | 1.00 % |
| ISIN-code | SE0006991246 |
| Maturity | 2022-04-08 |
| Tendered volume, SEK mln | 800 +/- 400 |
| Volume offered, SEK mln | 5,141 |
| Volume bought, SEK mln | 800 |
| Number of bids | 11 |
| Number of accepted bids | 3 |
| Average yield | -0.097 % |
| Lowest accepted yield | -0.098 % |
| Highest yield | -0.095 % |
| % accepted at lowest yield | 37.50 |
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Tiziana Life Sciences Ltd.16.1.2026 20:45:30 CET | Press release
Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares
Genmab A/S16.1.2026 19:30:00 CET | Press release
Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Novartis Pharma AG16.1.2026 18:00:00 CET | Press release
Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjögren’s disease
Aspo Plc16.1.2026 17:30:00 CET | Press release
Aspo Plc: Share repurchase 16.1.2026
Scatec ASA16.1.2026 17:00:00 CET | Press release
Invitation to presentation of Scatec ASA’s fourth quarter results 2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom